Published in Am J Public Health Nations Health on August 01, 1934
Diphtheria Studies II-Use of Intradermal Injections of Toxin-Toxoid Mixtures in Diphtheria Immunization. Am J Public Health Nations Health (1935) 0.96
The Pseudo-Schick Reaction and the Intradermol Toxoid Test of Moloney: their Relationship and Significance. J Hyg (Lond) (1935) 0.75
Laboratory: Dissociation of the Rawlings Strains of B. Typhosus. Am J Public Health Nations Health (1928) 12.95
Reimmunization Against Diphtheria of Previously Immunized Children. Am J Public Health Nations Health (1942) 7.70
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry (1995) 7.19
OBSERVATIONS ON THE VIABILITY OF THE BACTERIUM COLI GROUP UNDER NATURAL AND ARTIFICAL CONDITIONS. Am J Public Health (N Y) (1923) 4.01
Diphtheria Immunization with Fluid Toxoid and Alum-Precipitated Toxoid. Am J Public Health Nations Health (1942) 3.95
LABORATORY: A NEW METHOD FOR STAINING NEGRI BODIES OF RABIES. Am J Public Health (N Y) (1927) 3.23
MILK-BORNE DISEASE IN MASSACHUSETTS. Am J Public Health (N Y) (1927) 3.11
Milk-Borne Disease in Massachusetts, 1927-1929. Am J Public Health Nations Health (1930) 2.86
A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry (1982) 2.75
Comparative Speed of Response of Previously Immunized and Non-Immunized Children to Fluid and Alum-Precipitated Diphtheria Toxoid. Am J Public Health Nations Health (1943) 2.49
The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry (1990) 2.41
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A (2005) 2.38
Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry (1999) 2.32
Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A (2004) 2.19
Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial. Hepatology (1991) 2.15
Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. Arch Gen Psychiatry (1999) 2.03
Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry (1996) 1.84
Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry (1993) 1.80
Diphtheria Immunization With Fluid Toxoid and Alum Precipitated Toxoid -Preliminary Report. Am J Public Health Nations Health (1939) 1.73
A Ten-Year Study of Toxin-Antitoxin Mixture and the Schick Test in the Control of Institutional Diphtheria. Am J Public Health Nations Health (1932) 1.69
Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neuropsychopharmacology (1997) 1.63
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59
Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry (1982) 1.58
Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci (1996) 1.50
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry (2010) 1.42
PUBLIC HEALTH TRAINING. Am J Public Health (N Y) (1926) 1.39
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc Natl Acad Sci U S A (2000) 1.37
Laboratory: The Cultivation of Endameba Gingivalis (Gros) from the Human Mouth. Am J Public Health Nations Health (1929) 1.33
GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex (1996) 1.31
Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry (1982) 1.30
Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry (1993) 1.30
Leukocytosis during lithium treatment. Am J Psychiatry (1971) 1.27
A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry (1983) 1.26
Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. Life Sci (1989) 1.25
Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry (1965) 1.24
Stress-induced changes in primate prefrontal profiles of gene expression. Mol Psychiatry (2007) 1.18
Pertussis agglutinins in adults. Public Health Rep (1969) 1.16
Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology (Berl) (1993) 1.15
Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry (1969) 1.13
Antibody response to booster dose of diphtheria and tetanus toxoids: Reactions in institutionalized adults and non-institutionalized children and young adults. Public Health Rep (1963) 1.13
Stimulation by lithium of monoamine uptake in human platelets. Life Sci (1969) 1.11
PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry (1996) 1.11
Quantitative studies of norepinephrine uptake by synaptosomes. Biochem Pharmacol (1968) 1.11
Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A (1998) 1.11
DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles. Neurobiol Dis (2003) 1.10
Evidence for an excess of B→D*τ(-)ν(τ) decays. Phys Rev Lett (2012) 1.10
Observation of time-reversal violation in the B0 meson system. Phys Rev Lett (2012) 1.09
Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. Lancet (1968) 1.09
Precise measurement of the e+e- --> pi+pi-(gamma) cross section with the initial state radiation method at BABAR. Phys Rev Lett (2009) 1.07
The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. Sleep (1991) 1.07
L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients. Biol Psychiatry (1970) 1.07
Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature (1977) 1.07
LABORATORY: THE BUCK PLATE COLONY COUNTER. Am J Public Health Nations Health (1928) 1.07
Measurement of |V(cb)| and the form-factor slope in B --> Dl- nu(l) decays in events tagged by a fully reconstructed B meson. Phys Rev Lett (2010) 1.05
Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry (1992) 1.05
The inheritance of affective disorders: a review of data and of hypotheses. Behav Genet (1976) 1.03
Seasonal affective disorder: prevalence varies with latitude and climate. Clin Neuropharmacol (1986) 1.03
Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia. Mol Psychiatry (2003) 1.03
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berl) (1980) 1.02
Lithium response in unipolar versus bipolar depression. Am J Psychiatry (1972) 1.01
Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clin Cancer Res (1999) 1.01
The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch Gen Psychiatry (1972) 1.00
Age-related changes in sleep in depressed and normal subjects. Psychiatry Res (1981) 0.99
Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry (1993) 0.99
Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays. J Natl Cancer Inst (1978) 0.99
L-tryptophan in affective disorders: indoleamine changes and differential clinical effects. Psychopharmacologia (1974) 0.98
Gender differences in gating of the auditory evoked potential in normal subjects. Biol Psychiatry (1996) 0.98
S-adenosylmethionine treatment of depression: a controlled clinical trial. Am J Psychiatry (1988) 0.97
Effect of L-DOPA on depression. Lancet (1969) 0.97
Pituitary adrenal function and depression. An outline for research. Arch Gen Psychiatry (1967) 0.97
A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects. Arch Gen Psychiatry (1983) 0.97
Diphtheria Studies II-Use of Intradermal Injections of Toxin-Toxoid Mixtures in Diphtheria Immunization. Am J Public Health Nations Health (1935) 0.96
Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients. Arch Gen Psychiatry (1969) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
Surgical stress in humans is accompanied by an increase in plasma beta-endorphin immunoreactivity. Life Sci (1981) 0.96
Effects of temporal variability on p50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trial analysis. Arch Gen Psychiatry (2000) 0.95
Ageing, monoamines, and monoamine-oxidase levels. Lancet (1972) 0.95
Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res (1997) 0.95
Laboratory. Am J Public Health Nations Health (1930) 0.94
The "switch process" in manic-depressive illness. I. A systematic study of sequential behavioral changes. Arch Gen Psychiatry (1972) 0.93
Color blindness not closely linked to bipolar illness. Report of a new pedigree series. Arch Gen Psychiatry (1979) 0.93
Physiological effects of high dose naloxone administration to normal adults. Life Sci (1982) 0.93
Phosphorylation and Cu+ coordination-dependent DNA binding of the transcription factor Mac1p in the regulation of copper transport. J Biol Chem (2000) 0.93
Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. Arch Gen Psychiatry (1983) 0.93
Adrenal cortical activity in depressive illness. Am J Psychiatry (1971) 0.93
Coding SNPs included in exon arrays for the study of psychiatric disorders. Mol Psychiatry (2008) 0.92
Collection and Identification of Allelopathic Compounds from the Undisturbed Root System of Bigalta Limpograss (Hemarthria altissima). Plant Physiol (1982) 0.92
Endocrine effects of the cold pressor test: relationships to subjective pain appraisal and coping. Psychiatry Res (1984) 0.92
Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study. Arch Gen Psychiatry (1969) 0.92
Depressions following reserpine: a reevaluation. Semin Psychiatry (1971) 0.91
Positron emission tomography with deoxyglucose-F18 imaging of sleep. Neuropsychopharmacology (2001) 0.91
A dopaminergic mechanism in mania. Am J Psychiatry (1976) 0.91
Effect of lithium on the uptake of noradrenaline by synaptosomes. Nature (1967) 0.91
Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry (1997) 0.91
Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients. Nature (1971) 0.90
Possible receptor effects of chronic lithium administration. Neuropharmacology (1983) 0.90